Onconova Therapeutics (ONTX) Announces Encouraging Clinical Data Supporting the Anti-Cancer Activity of Rigosertib-Nivolumab Combination in Advanced KRAS+ Non-Small Cell Lung Cancer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| ONCONOVA THERAPTCS (NYSE: ONTX) | Delayed: 7.18 -0.03 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.21 | 52 Week High | $6.71 | |||
| Open | $7.24 | 52 Week Low | $0.32 | |||
| Day High | $7.74 | P/E | N/A | |||
| Day Low | $7.07 | EPS | $-2.36 | |||
| Volume | 244,996 | |||||
